Palisade Capital Management LLC Abbott Laboratories Transaction History

Palisade Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$95.53 - $114.62 $14,329 - $17,193	-150 Reduced 5.26%	2,700 $261,000
Q2 2022 Aug 10, 2022	SELL	$102.07 - $123.37 $8,880 - $10,733	-87 Reduced 2.96%	2,850 $310,000
Q1 2022 May 09, 2022	BUY	$114.02 - $139.04 $9,919 - $12,096	87 Added 3.05%	2,937 $348,000
Q2 2021 Aug 12, 2021	SELL	$105.79 - $124.53 $14,493 - $17,060	-137 Reduced 4.59%	2,850 $330,000
Q1 2021 May 12, 2021	BUY	$108.84 - $128.23 $14,911 - $17,567	137 Added 4.81%	2,987 $358,000
Q1 2019 May 13, 2019	SELL	$66.22 - $80.06 $6,489 - $7,845	-98 Reduced 3.32%	2,850 $228,000
Q4 2018 Feb 12, 2019	BUY	$65.56 - $74.27 $6,424 - $7,278	98 Added 3.44%	2,948 $213,000
Q3 2018 Nov 14, 2018	BUY	$60.81 - $73.36 $173,308 - $209,076	2,850 New	2,850 $209,000

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Palisade Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Palisade Capital Management LLC with notifications on news.